Human immunity to the meningococcus. I. The role of humoral antibodies.
about
Vaccines for gonorrhea: can we rise to the challenge?Conjugate vaccines for preventing meningococcal C meningitis and septicaemiaConjugate vaccines for preventing meningococcal C meningitis and septicaemiaUse of licensed vaccines for active immunization of the immunocompromised hostProspects for vaccine prevention of meningococcal infectionImmune response induction and new effector mechanisms possibly involved in protection conferred by the Cuban anti-meningococcal BC vaccineImmunogenicity of intranasally administered meningococcal native outer membrane vesicles in miceBranhamella catarrhalis: epidemiology, surface antigenic structure, and immune responseThe neglected role of antibody in protection against bacteremia caused by nontyphoidal strains of Salmonella in African childrenMeningococcal VaccinationsMeningococcal B vaccine and the vision of a meningitis free worldMeningococcal B vaccination strategies and their practical application in ItalyWill there ever be a universal Staphylococcus aureus vaccine?Role of factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal diseaseImportance of circulating antibodies in protection against meningococcal diseaseDesign and Evaluation of Meningococcal Vaccines through Structure-Based Modification of Host and Pathogen MoleculesStandardization of Neisseria meningitidis serogroup B colorimetric serum bactericidal assayThe meningococcal vaccine candidate neisserial surface protein A (NspA) binds to factor H and enhances meningococcal resistance to complementTranscriptional profiling of serogroup B Neisseria meningitidis growing in human blood: an approach to vaccine antigen discoveryImmunity against Neisseria meningitidis serogroup C in the Dutch population before and after introduction of the meningococcal c conjugate vaccineReview of meningococcal vaccines with updates on immunization in adultsInfections of People with Complement Deficiencies and Patients Who Have Undergone SplenectomyCan Neisseria lactamica antigens provide an effective vaccine to prevent meningococcal disease?Fine antigenic specificity and cooperative bactericidal activity of monoclonal antibodies directed at the meningococcal vaccine candidate factor h-binding proteinRecent Progress in the Prevention of Serogroup B Meningococcal Disease.Multicomponent meningococcal B vaccination (4CMenB) of adolescents and college students in the United StatesCharacteristics of a new meningococcal serogroup B vaccine, bivalent rLP2086 (MenB-FHbp; Trumenba®).Escherichia coli K51 and K93 capsular polysaccharides are crossreactive with the group A capsular polysaccharide of Neisseria meningitidis. Immunochemical, biological, and epidemiological studies.Infectious diseases associated with complement deficiencies.How to make sense of pertussis immunogenicity data.Pathogen proteins eliciting antibodies do not share epitopes with host proteins: a bioinformatics approach.Immunogenicity of fractional doses of tetravalent a/c/y/w135 meningococcal polysaccharide vaccine: results from a randomized non-inferiority controlled trial in UgandaAssociation of a bacteriophage with meningococcal disease in young adults.Towards the immunoproteome of Neisseria meningitidisThe influence of IS1301 in the capsule biosynthesis locus on meningococcal carriage and disease.Preparation, characterization, and immunogenicity of meningococcal lipooligosaccharide-derived oligosaccharide-protein conjugatesDevelopment and use of a serum bactericidal assay using pooled human complement to assess responses to a meningococcal group A conjugate vaccine in African toddlers.Phase variation mediates reductions in expression of surface proteins during persistent meningococcal carriage.Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and haemophilus influenzae type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vaccCritical roles of complement and antibodies in host defense mechanisms against Neisseria meningitidis as revealed by human complement genetic deficiencies.
P2860
Q21131153-B9CF3FAC-5525-4B0D-8DF4-072629C8679BQ24235722-5FC55884-FAA1-441D-AFAC-E97F68E05927Q24244951-76D8B34A-E1A9-4A55-B286-5B0E2FEFC5AAQ24533456-64C1D3E7-EFAD-477A-99E1-68FD8226EDA9Q24537338-5293B829-1EF2-4185-ABAD-839E44B92F9BQ24548670-430D9097-D918-4BFF-A6EC-05522F52AF9CQ24548847-D5E0B5ED-7889-48AC-947A-A027DB4F10EFQ24650974-E673C88A-5306-40F4-965A-7386BCB9ED94Q24651695-FDC584BF-2B60-4B84-80C3-E25B01ED4BFBQ26752993-92BE5F91-CF9B-48F6-B19E-C433745568CCQ26770696-4FFE3C82-78C7-4AEB-9D99-9B273A40AFA8Q26770699-F3F85D58-AE46-428D-9D94-7A99D8F8A0B0Q26824837-D490DAA3-9BA8-464A-97B6-0D73E824E523Q26995760-71A38126-0A76-41F8-93B8-F70FA38327B5Q27023516-10DAABF5-F6B3-4EE1-AD81-2567F92CADFDQ27675010-88F27519-A4DB-4EA0-A195-1FAF0CEA210BQ28344521-9F89FA07-4057-4C07-BF0D-83F4EB54BB5BQ28474974-D70C7C26-701E-4933-AE30-98FD35C02A52Q28728122-3C5A6C6F-AC41-47B4-8AA9-0220583E07FAQ28749695-F8714317-D2AA-46C6-A829-CD1E7F0D6734Q28828692-57C4B47A-55B8-4BF8-9BE8-9ED59B6D605FQ28972389-BAF9B28E-02F0-4FF8-B7EB-ACD1BBF780DEQ30150784-4E3D7FF7-CAD4-4689-B510-4A879D401978Q30157650-9205B8FB-87EE-40D9-9676-F0009E039E07Q30235040-ED0F81D4-F9FA-4335-9F07-2F8A0003ECB8Q30235072-F8C8D491-A311-48FF-8405-32D644C64C38Q30248749-B7A02E09-D9EA-4003-9512-76D3D2D1859AQ30442755-BCDFFFF3-FD3B-48B8-B516-E0EC75B16223Q30450183-FB263252-7708-40E4-9740-45EC1A3088E6Q30665598-97487529-4CA2-4C0D-B03A-0878F2ABF188Q33286824-536AF3CB-1E74-4ACD-B893-A722240B9964Q33388680-ABD02E08-EB6F-43C6-95E4-4ED4933DC4E4Q33391053-491BE697-C5AD-401C-8BE4-8E2C87D99E75Q33468425-5F213C21-C805-4A82-88C8-63910C209383Q33535924-E3CDA5FF-B5D7-48D7-9CA6-B27F99A1824CQ33595722-E6195638-B188-48FB-BC06-70A4AFDAAC9CQ33601899-CF26FCFB-1F1C-4265-B7C6-37E3B3FE1165Q33603065-3EFCEFD6-B6C5-4BB9-A4CD-459E24FA1D98Q33613482-A43F7177-1804-43C8-9C56-70CA4BDFF5E2Q33613839-988F0D27-949C-465F-BA2B-C8B5B451A3AB
P2860
Human immunity to the meningococcus. I. The role of humoral antibodies.
description
1969 nî lūn-bûn
@nan
1969年の論文
@ja
1969年学术文章
@wuu
1969年学术文章
@zh-cn
1969年学术文章
@zh-hans
1969年学术文章
@zh-my
1969年学术文章
@zh-sg
1969年學術文章
@yue
1969年學術文章
@zh
1969年學術文章
@zh-hant
name
Human immunity to the meningococcus. I. The role of humoral antibodies.
@ast
Human immunity to the meningococcus. I. The role of humoral antibodies.
@en
type
label
Human immunity to the meningococcus. I. The role of humoral antibodies.
@ast
Human immunity to the meningococcus. I. The role of humoral antibodies.
@en
prefLabel
Human immunity to the meningococcus. I. The role of humoral antibodies.
@ast
Human immunity to the meningococcus. I. The role of humoral antibodies.
@en
P2093
P2860
P356
P1476
Human immunity to the meningococcus. I. The role of humoral antibodies.
@en
P2093
Artenstein MS
Goldschneider I
Gotschlich EC
P2860
P304
P356
10.1084/JEM.129.6.1307
P407
P577
1969-06-01T00:00:00Z